Skip to main content
. 2023 Mar 31;10:1156062. doi: 10.3389/fmolb.2023.1156062

TABLE 1.

The primer sequences.

Target gene Primer sequence (5′to 3′) Size (bp)
Name Id Forward Reverse
ACSL4 2,182 ATA​CCT​GGA​CTG​GGA​CCG​AA TGC​TGG​ACT​GGT​CAG​AGA​GT 145
TfR1 7,037 TGG​AGA​CTT​TGG​ATC​GGT​TGG​TG CAG​TGG​CTG​GCA​GAA​ACC​TTG 138
NCOA4 8031 GGG​CAA​CCT​CAG​CCA​GTT​AT CAA​ACT​GCA​GGG​AGG​CCA​TA 139
FTH1 2,495 CCA​GAA​CTA​CCA​CCA​GGA​CTC CAA​AGC​CAC​ATC​ATC​GCG​G 118
GPX4 2,879 CAG​TGA​GGC​AAG​ACC​GAA​GT CCG​AAC​TGG​TTA​CAC​GGG​AA 104
xCT 23657 CAT​CTC​TCC​TAA​GGG​CGT​GC TAG​TGA​CAG​GAC​CCC​ACA​CA 85
H O -1 3162 CCG​CAT​GAA​CTC​CCT​GGA​GAT​G CTG​GAT​GTT​GAG​CAG​GAA​CGC​AG 85
β-actin 60 CCTGGCACCCAGCACAAT GGGCCGGACTCGTCATAC 114

ACSL4: acyl-CoA, synthetase long-chain family member 4; NCOA4: nuclear receptor coactivator 4; FTH1: ferritin heavy chain 1; GPX4: glutathione peroxidase 4; H O -1: heme oxygenase 1; xCT: cystine-glutamate antiporter; TfR1: transferrin receptor 1.